Search

everythinglearnresearchcommunity

for

Search:↓

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

NLRP3 helps control inflammation and repair in wound healing, making it a potential target for treatment.

Atopy and altered T cell functions contribute to Alopecia Areata.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Schizophrenia risk genes may affect early brain development, contributing to the disease.

Mental and social factors greatly affect skin conditions and doctors find it hard to deal with these aspects.

Testosterone affects brain functions and contributes to sex differences, influencing conditions like autism.

Chronic skin diseases and metabolic syndrome are linked by shared inflammation pathways.

MicroRNAs play a crucial role in skin and hair health, affecting everything from growth to aging, and could potentially be used in treating skin diseases.

Women with androgenetic alopecia have noticeable changes in their autonomic nervous system.

Stress turns hair white by depleting color-giving cells in hair follicles through a specific neurotransmitter related to the body's stress response.

Social isolation makes mice more sensitive to alcohol's effects on brain function.

IL-1 promotes fat cell growth in skin, while WNT inhibits it and encourages scar formation.

A natural steroid in the body may protect against eye damage in glaucoma.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.

PCOS involves immune system issues and inflammation, possibly leading to autoimmune diseases.

Light can turn on hair growth cells through a nerve path starting in the eyes.

Blocking certain proteins on immune cells may help treat alopecia areata.

The skin's bacteria might influence the development of a hair loss condition called alopecia areata.

Early treatment of COVID-19-related hair loss is crucial for better outcomes.

Early NAS level changes affect alcohol consumption vulnerability.

New treatments for atopic dermatitis and alopecia areata have been developed using a targeted approach.

Stress can slow hair growth and affect skin color by impacting the body's stress response system.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Hair follicle stem cells might help treat traumatic brain injury.

Alopecia areata is linked to reduced T cell function and auto-immunity.

Neurosteroids may help prevent seizures and slow epilepsy progression.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.